Immunotherapy in high-risk chemotherapy-resistant patients with metastatic solid tumors and hematological malignancies using intentionally mismatched donor lymphocytes activated with rIL-2: a phase I study
Titel:
Immunotherapy in high-risk chemotherapy-resistant patients with metastatic solid tumors and hematological malignancies using intentionally mismatched donor lymphocytes activated with rIL-2: a phase I study
Auteur:
Slavin, Shimon Ackerstein, Aliza Or, Reuven Shapira, Michael Y. Gesundheit, Benjamin Askenasy, Nadir Morecki, Shoshana